Consint.AI, a deeptech startup specializing in AI-driven risk management for healthcare and insurance, has successfully raised ₹22 crore, approximately $2.3 million, in its Series A funding round. The investment was led by prominent technology backers including BIG Global Investment JSC, Equanimity Ventures Trust II, and Seafund Venture India Scheme I. This new capital injection is set to accelerate the company's next phase of growth and solidify its position in the enterprise AI market.
Strategic Global Expansion and AI Development
The company intends to strategically deploy the fresh capital to fuel its expansion into key international markets, including the United States, the Middle East, and Southeast Asia. A significant portion of the funds is also earmarked for deepening its artificial intelligence research and strengthening its enterprise delivery capabilities. This investment will be crucial for enhancing its portfolio of AI-powered solutions for the healthcare and insurance sectors on a global scale.
Building a Foundational Model for Fraud Detection
A core focus of this funding round is the development of a foundational model specifically designed for detecting fraud, waste, and abuse. This advanced model aims to serve a wide range of clients, from insurers and healthcare providers to government health programs. It will power the startup's flagship platforms, Risk.ai and CIPHR.ai, to deliver higher accuracy and faster inference in identifying financial misconduct.
A Suite of Intelligent Automation Platforms
Consint.AI offers a comprehensive suite of proprietary platforms designed to automate complex operational workflows for its enterprise clients. Its Risk.AI platform identifies fraudulent transactions and assesses underwriting risks, while CIPHR.ai standardizes patient health records for clinical workflows. Other solutions like AutoClaim AI and DocInsight AI further streamline claims processing and document digitization using advanced AI and natural language processing.
Proven Impact and Scalable Performance
The company has already demonstrated significant impact, having assessed over 100 million transactions on its platforms to date. By leveraging more than 500 proprietary AI and machine learning models, Consint.AI claims to have identified over ₹1,000 crore in potential fraud. This track record highlights the effectiveness of its technology in helping organizations reduce financial losses and improve operational efficiency.
Leadership Vision and Market Positioning
Ashish Chaturvedi, Founder and CEO of Consint.AI, stated that the funding validates the company's vision to transform industry operations through AI. He emphasized that the capital allows the company to properly build its specialized fraud detection model and expand its global footprint. The goal is to deliver intelligent solutions that reduce risk, improve efficiency, and create better outcomes for both patients and policyholders.
Strengthening Operational Excellence
According to COO Preeti Chaturvedi, this investment reinforces the strong operational foundation the company has built over the years. The focus remains on delivering AI solutions that solve tangible, real-world challenges for healthcare providers and insurers. This funding will enable the company to enhance its delivery capabilities and continue building scalable, secure, and enterprise-ready AI platforms for its growing customer base.
This Series A funding marks a pivotal milestone for Consint.AI, providing the necessary resources to scale its innovative solutions across international markets. The investment not only validates the company's technology and vision but also positions it to capitalize on the increasing global demand for intelligent fraud detection. As industries accelerate their adoption of AI, Consint.AI is well-equipped to lead the charge in enterprise risk management.